alphaveVAISHALI₹8.59

Vaishali Pharma Limited

· Unclassified

Annual Quarterly₹ CrorePeersTEMBO TOTAL OSWALSEEDS GROBTEA BEARDSELL HINDCON CROWN ARTNIRMANMcap ₹56 Cr

View

In ₹ Crore except Per Share 12 Months Ending	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	33.4	24.7	26.9	22.9
Other Income	0.8	0.9	1.3	0.6
Total Income	34.3	25.5	28.2	23.5
Expenses
+ Purchases of Stock-in-Trade	28.0	19.6	27.3	17.3
+ Changes in Inventories	1.7	1.4	-2.9	2.1
+ Employee Benefit Expense	0.6	0.7	0.8	0.7
+ Finance Costs	0.4	0.5	0.7	0.2
+ Depreciation & Amortisation	0.2	0.1	0.2	0.1
+ Other Expenses	1.7	1.4	1.9	1.2
Total Expenses	32.6	23.7	28.0	21.7
EBITDA	1.4	1.6	-0.2	1.5
EBIT	1.2	1.4	-0.4	1.3
Profit
PBT before Exceptional Items	1.7	1.8	0.2	1.7
Pretax Income	1.7	1.8	0.2	1.7
+ Current Tax	0.4	0.4	0.0	0.4
+ Deferred Tax	0.0	0.1	-0.1	-0.1
Tax Expense	0.5	0.5	-0.1	0.2
+ Share of Associates & JVs	0.0	0.0	0.1	0.1
Net Income	1.2	1.3	0.4	1.5
+ Net Income — Continuing Ops	1.2	1.3	0.3	1.5
+ Other Comprehensive Income	0.0	0.0	0.0	-0.0
Total Comprehensive Income	1.2	1.3	0.4	1.5
Per Share
Basic EPS	0.09	0.10	0.03	0.12
Diluted EPS	0.09	0.10	0.03	0.12
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	0.0	-0.0
+ Items NOT to be Reclassified to P&L	—	—	0.0	—
+ Tax on Items NOT to be Reclassified	—	—	0.0	—
+ Items to be Reclassified to P&L	—	—	—	-0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	0.09	0.10	0.03	0.12
Diluted EPS — Continuing Operations	0.09	0.10	0.03	0.12
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	3.7	3.7	2.5	3.5
Gross Margin %	11.21	15.07	9.17	15.07
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	1.7	1.8	0.2	1.7
Net Income Adj (tax-effected)	1.2	1.3	0.4	1.5
EPS Adj	0.09	0.10	0.03	0.12
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00
Paid Up Equity Capital	13.0	26.1	13.0	13.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.